75 related articles for article (PubMed ID: 9706131)
1. Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding.
delaTorre A; Schroeder RA; Bartlett ST; Kuo PC
Surgery; 1998 Aug; 124(2):137-41; discussion 141-2. PubMed ID: 9706131
[TBL] [Abstract][Full Text] [Related]
2. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation.
DelaTorre A; Schroeder RA; Kuo PC
Biochem Biophys Res Commun; 1997 Sep; 238(3):703-6. PubMed ID: 9325152
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages.
delaTorre A; Schroeder RA; Punzalan C; Kuo PC
J Immunol; 1999 Apr; 162(7):4101-8. PubMed ID: 10201934
[TBL] [Abstract][Full Text] [Related]
4. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.
Grumbach IM; Chen W; Mertens SA; Harrison DG
J Mol Cell Cardiol; 2005 Oct; 39(4):595-603. PubMed ID: 16099468
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-kappa B by S-nitrosylation.
Marshall HE; Stamler JS
Biochemistry; 2001 Feb; 40(6):1688-93. PubMed ID: 11327828
[TBL] [Abstract][Full Text] [Related]
6. Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta.
Pelzer T; Neumann M; de Jager T; Jazbutyte V; Neyses L
Biochem Biophys Res Commun; 2001 Sep; 286(5):1153-7. PubMed ID: 11527420
[TBL] [Abstract][Full Text] [Related]
7. Interaction of AP-1 with a cluster of NF-kappa B binding elements in the human TNF promoter region.
Udalova IA; Kwiatkowski D
Biochem Biophys Res Commun; 2001 Nov; 289(1):25-33. PubMed ID: 11708771
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of p21Ras S-nitrosylation and kinetics of nitric oxide-mediated guanine nucleotide exchange.
Heo J; Campbell SL
Biochemistry; 2004 Mar; 43(8):2314-22. PubMed ID: 14979728
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
11. Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes.
Jefferson KK; Smith MF; Bobak DA
J Immunol; 1999 Nov; 163(10):5183-91. PubMed ID: 10553038
[TBL] [Abstract][Full Text] [Related]
12. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
13. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by a novel compound, mercaptopyrazine, through suppression of nuclear factor-kappaB binding to DNA.
Lim S; Kang KW; Park SY; Kim SI; Choi YS; Kim ND; Lee KU; Lee HK; Pak YK
Biochem Pharmacol; 2004 Aug; 68(4):719-28. PubMed ID: 15276079
[TBL] [Abstract][Full Text] [Related]
15. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
Trinh DV; Zhu N; Farhang G; Kim BJ; Huxford T
J Mol Biol; 2008 May; 379(1):122-35. PubMed ID: 18436238
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
17. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-kappaB DNA binding by nitric oxide.
Matthews JR; Botting CH; Panico M; Morris HR; Hay RT
Nucleic Acids Res; 1996 Jun; 24(12):2236-42. PubMed ID: 8710491
[TBL] [Abstract][Full Text] [Related]
19. Proteomics insights into deregulated protein S-nitrosylation and disease.
López-Sánchez LM; López-Pedrera C; Rodríguez-Ariza A
Expert Rev Proteomics; 2012; 9(1):59-69. PubMed ID: 22292824
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide as a regulator of gene expression: studies with the transcription factor proteins cJun and p50.
Pineda-Molina E; Lamas S
Biofactors; 2001; 15(2-4):113-5. PubMed ID: 12016338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
